mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function declineKseniya Obraztsova, Vera P. Krymskaya, Maria C. Basil et al.|Nature Communications|2020Cited by 58
Hyperactive mTORC1 in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodelingSusan M. Lin, Vera P. Krymskaya, Akansha Goel et al.|Journal of Clinical Investigation|2023Cited by 18
The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in LymphangioleiomyomatosisJilly F. Evans, Vera P. Krymskaya, O. Ledwell et al.|American Journal of Respiratory Cell and Molecular Biology|2024Cited by 7
Extracellular Matrix and Fibroblast Activation in LymphangioleiomyomatosisAlexander R. Mukhitov, Vera P. Krymskaya, Jilly F. Evans et al.|American Journal of Respiratory Cell and Molecular Biology|2025Cited by 1
Abnormal Alveolar Architecture in Lymphangioleiomyomatosis (LAM) Lungs Is a Result of Defective Epithelial-Mesenchymal CrosstalkKseniya Obraztsova, Vera P. Krymskaya, Maria C. Basil et al.|Unknown|2020Cited by 0